NDT Pharmaceuticals (NDTP) Income Statement

10 Followers

NDT Pharmaceuticals Income Statement

Last quarter (Q2 2026), NDT Pharmaceuticals's total revenue was $156.13K, an increase of Infinity% from the same quarter last year. In Q2, NDT Pharmaceuticals's net income was $-715.48K. See NDT Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 23
Total Revenue	$ 0.00
Gross Profit	$ 0.00
Operating Expenses	$ 25.17K
Depreciation and Amortization	$ 167.90K
EBITDA	$ 88.87K
Operating Income	$ -25.17K
Other Income/Expenses	$ -53.86K
Pretax Income	$ -79.03K
Net Income	$ -79.03K
Per Share Metrics
Basic EPS	$ 0.00
Diluted EPS	$ 0.00
Weighted Average Shares Outstanding	160.00M
Weighted Average Shares Outstanding (Diluted)	160.00M

Currency in USD

NDT Pharmaceuticals (NDTP) Income Statement

NDT Pharmaceuticals Income Statement

NDT Pharmaceuticals Earnings and Revenue History